Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours

Histopathology

Volumn 62, Issue 4, 2013, Pages 657-661

  Matsubara, Akiko ^a   Sekine, Shigeki ^b   Yoshida, Masayuki ^a   Yoshida, Akihiko ^a   Taniguchi, Hirokazu ^a   Kushima, Ryoji ^a   Tsuda, Hitoshi ^a   Kanai, Yae ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Leiomyoma; Leiomyosarcoma; MED12

Indexed keywords

ARTICLE; FEMALE; GASTROINTESTINAL TUMOR; GENE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOMA; LEIOMYOSARCOMA; LIPOLEIOMYOMA; MED12 GENE; MISSENSE MUTATION; MUSCLE TUMOR; MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SOFT TISSUE TUMOR; UTERUS TUMOR;

DNA MUTATIONAL ANALYSIS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LEIOMYOMA; MEDIATOR COMPLEX; MUTATION; RETROPERITONEAL NEOPLASMS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 84874201565     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12039     Document Type: Article

References (8)

1. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best. Pract. Res. Clin. Obstet. Gynaecol. 2008; 22; 571-588.
2. Makinen N, Mehine M, Tolvanen J et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011; 334; 252-255.
3. McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One 2012; 7; e33251.
4. Perot G, Croce S, Ribeiro A et al. MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One 2012; 7; e40015.
5. Hendrickson M, Tavassoli F, Kempson R, McCluggage W, Haller U, Kubik-Huch R. Mesenchymal tumours and related lesions. In Tavassoli F, Devilee P eds. Tumours of the breast and female genital organs. Lyon: IARC Press, 2003; 233-249.
6. Markowski DN, Bartnitzke S, Loning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups. Int. J. Cancer 2012; 131; 1528-1536.
7. Je EM, Kim MR, Min KO, Yoo NJ, Lee SH. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int. J. Cancer 2012; 131; E1044-E1047.
8. Mittal KR, Chen F, Wei JJ et al. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod. Pathol. 2009; 22; 1303-1311.